TABLE 5.
T-cell line | IFN-γ production a (pg/ml) with:
|
||||||
---|---|---|---|---|---|---|---|
MIM
|
rAg85B
|
IL-12 productionb (pg/ml) with:
|
|||||
− IL-12 | + IL-12 | + anti– IL-12 | − IL-12 | + IL-12 | MIM | MIM + PBMCb | |
Mtb.187 | <5 | 174 | <5 | ND | ND | 7 | <5 |
Mtb.191 | 65 | 184 | 63 | ND | ND | <5 | 10 |
Mtb.184 | 34 | 599 | 50 | 97 | 206 | 30 | 17 |
Mtb.193 | 82 | 397 | 141 | 22 | 77 | 7 | 14 |
Mtb.186 | 129 | 1,510 | ND | 12 | 394 | <5 | <5 |
Mtb T-cell lines were generated by stimulating normal PBMC with MIM in the absence (−) or presence (+) of IL-12 (1 ng/ml) or neutralizing antibody to IL-12 (100 μg). They were challenged in vitro with MIM or rAg85B-pulsed normal macrophages for 3 days. Supernatants were harvested at 72 h, and IFN-γ production was determined by an ELISA. ND, not determined.
Mature macrophages (from donors 187, 191, 184, 193, and 186) were infected with MIM (ratio, 20:1) or mock infected (data not shown). After 2 days, autologous naive PBMC were cocultured with MIM. Supernatants were harvested at 48 h and tested for IL-12 p70 by an ELISA.